Figure 4

From: Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence

Figure 4

MYO5B is a prognostic marker in CRC patients. (A and B) Overall (A), n=585 and relapse-free (B), n=574 survival in CRC patients stratified according to MYO5B expression in the GSE39582 data set. (C and D) Overall (C) and relapse-free (D) survival in early stage (stages I and II) CRC patients stratified according to MYO5B expression in the GSE39582 data set. (E) Disease-free survival curves for patients with ‘high’ and ‘low’ expression levels of MYO5B in an independent data set (GSE24551) covering 160 patients. (F) Metastasis-free survival based on ‘high’ or ‘low’ expression of MYO5B in a data set (GSE28814) containing clinical data on metastasis from 125 CRC patients. Patient numbers and associated P-values are indicated in the figures.